HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by FAS Wealth Partners Inc.

FAS Wealth Partners Inc. decreased its holdings in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 3.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,140 shares of the company’s stock after selling 46 shares during the quarter. FAS Wealth Partners Inc.’s holdings in HCA Healthcare were worth $309,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of HCA. abrdn plc raised its stake in HCA Healthcare by 4.8% during the third quarter. abrdn plc now owns 164,419 shares of the company’s stock valued at $40,444,000 after buying an additional 7,476 shares in the last quarter. DNB Asset Management AS raised its stake in HCA Healthcare by 14.1% during the fourth quarter. DNB Asset Management AS now owns 60,682 shares of the company’s stock valued at $16,425,000 after buying an additional 7,476 shares in the last quarter. Soros Fund Management LLC acquired a new stake in HCA Healthcare during the third quarter valued at approximately $10,085,000. Comerica Bank boosted its position in HCA Healthcare by 623.3% during the 3rd quarter. Comerica Bank now owns 43,502 shares of the company’s stock valued at $10,701,000 after purchasing an additional 37,488 shares during the period. Finally, Handelsinvest Investeringsforvaltning bought a new stake in HCA Healthcare in the fourth quarter valued at $1,100,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Down 0.2 %

Shares of HCA Healthcare stock opened at $329.35 on Wednesday. The stock has a 50-day moving average price of $313.78 and a 200 day moving average price of $274.88. The company has a market cap of $87.11 billion, a P/E ratio of 17.35, a P/E/G ratio of 1.66 and a beta of 1.65. The company has a current ratio of 1.18, a quick ratio of 1.02 and a debt-to-equity ratio of 35.07. HCA Healthcare, Inc. has a 1 year low of $215.96 and a 1 year high of $334.49.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its quarterly earnings results on Tuesday, January 30th. The company reported $5.90 earnings per share for the quarter, topping analysts’ consensus estimates of $5.05 by $0.85. HCA Healthcare had a return on equity of 996.30% and a net margin of 8.07%. The company had revenue of $17.30 billion during the quarter, compared to the consensus estimate of $16.51 billion. During the same period last year, the business earned $4.64 EPS. The business’s quarterly revenue was up 11.7% on a year-over-year basis. As a group, analysts expect that HCA Healthcare, Inc. will post 20.49 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 29th. Shareholders of record on Friday, March 15th were issued a $0.66 dividend. The ex-dividend date of this dividend was Thursday, March 14th. This represents a $2.64 dividend on an annualized basis and a yield of 0.80%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.60. HCA Healthcare’s dividend payout ratio (DPR) is 13.91%.

HCA Healthcare declared that its board has approved a stock buyback program on Tuesday, January 30th that authorizes the company to buyback $6.00 billion in shares. This buyback authorization authorizes the company to reacquire up to 7.4% of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s board of directors believes its shares are undervalued.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on HCA. Wells Fargo & Company boosted their target price on shares of HCA Healthcare from $303.00 to $315.00 and gave the company an “equal weight” rating in a research note on Thursday, March 28th. StockNews.com lowered HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Thursday, February 15th. Royal Bank of Canada increased their target price on shares of HCA Healthcare from $308.00 to $322.00 and gave the company an “outperform” rating in a research report on Wednesday, January 31st. Oppenheimer reiterated an “outperform” rating and issued a $315.00 price objective on shares of HCA Healthcare in a report on Wednesday, January 17th. Finally, Raymond James increased their price target on HCA Healthcare from $300.00 to $330.00 and gave the company an “outperform” rating in a research note on Wednesday, January 31st. Four analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $311.47.

View Our Latest Stock Analysis on HCA Healthcare

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Chad J. Wasserman sold 876 shares of the firm’s stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $330.25, for a total value of $289,299.00. Following the sale, the senior vice president now owns 1,576 shares of the company’s stock, valued at approximately $520,474. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other news, SVP Chad J. Wasserman sold 876 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $330.25, for a total transaction of $289,299.00. Following the sale, the senior vice president now owns 1,576 shares of the company’s stock, valued at approximately $520,474. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Chad J. Wasserman sold 344 shares of HCA Healthcare stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $321.97, for a total value of $110,757.68. Following the sale, the senior vice president now directly owns 2,452 shares in the company, valued at approximately $789,470.44. The disclosure for this sale can be found here. Insiders have sold 14,840 shares of company stock valued at $4,588,869 in the last 90 days. 1.70% of the stock is currently owned by insiders.

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Articles

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.